Price T Rowe Associates Inc Collegium Pharmaceutical, Inc Transaction History
Price T Rowe Associates Inc
- $816 Billion
- Q1 2024
A detailed history of Price T Rowe Associates Inc transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Price T Rowe Associates Inc holds 29,282 shares of COLL stock, worth $927,068. This represents 0.0% of its overall portfolio holdings.
Number of Shares
29,282
Previous 28,747
1.86%
Holding current value
$927,068
Previous $885,000
28.47%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding COLL
# of Institutions
231Shares Held
39.5MCall Options Held
104KPut Options Held
15.4K-
Black Rock Inc. New York, NY5.87MShares$186 Million0.01% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.63MShares$83.4 Million1.65% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.59MShares$81.9 Million0.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.33MShares$73.8 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY1.83MShares$58.1 Million2.43% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.08B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...